<html>
<head>PUBMED IDs for MYO10</head>
<body bgcolor='#C5F0F2'><h1>MYO10</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15215162/'>TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.</a> June 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/20427544/'>MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation.</a> June 30  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23874428/'>Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma.</a> April 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24487586/'>Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.</a> May 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26573744/'>MiR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer.</a> October 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27120335/'>Genetic Candidate Variants in Two Multigenerational Families with Childhood Apraxia of Speech.</a> February 18  2016<br></body></html>
